Niclosavir Limited

At Niclosavir Limited, we're proud to introduce our innovative approach to tackling one of the dairy industry's biggest challenges: mastitis in dairy cattle. Mastitis is a costly and critical issue affecting dairy herds worldwide. With antimicrobial resistance on the rise, finding alternative treatments is more crucial than ever. Our solution aims to reduce reliance on antibiotics while ensuring the health and productivity of dairy cattle. We're dedicated to finding a sustainable solution that benefits both animals and the environment. If you’d like to support our efforts to treat this very costly disease, we’re welcoming all opportunities to help us on our exciting journey. Get in touch at info@niclosavir.com Interested in learning more about how Niclosavir could reshape the future of the dairy industry? Visit our website to learn more about our approach: https://lnkd.in/gJV59Cjq Read more about the importance of this topic in the latest research here: https://lnkd.in/gKtvuyNz #DairyFarming #AnimalHealth #Innovation #Sustainability #AntimicrobialResistance #Mastitis #NiclosavirLimited

The challenges facing the cattle and camel dairy industries are immense, including: 🦠 Mastitis 🥛 Poor milk quality ⤵️ Reduced production ❌ Premature culling of diseased animals. Did you know these issues collectively cost the dairy industry a staggering US$15 to US$23 billion annually? At Niclosavir Limited, we have risen to the challenge of finding a novel way to reduce the use of antibiotics to treat mastitis in dairy cattle. Antibiotic resistance is a growing concern, and we must find sustainable solutions to this costly disease. Our mission is to reduce reliance on antibiotics while enhancing animal welfare and safeguarding human health. Interested in learning more about how Niclosavir Ltd could reshape the future of the dairy industry? Visit our website to learn more about our approach: https://lnkd.in/gJV59Cjq If you would like to support our efforts to treat this very costly disease, please get in touch at info@niclosavir.com Visit the link below to find out more on this global issue: https://lnkd.in/gmEVrdEk #DairyIndustry #MastitisTreatment #AntimicrobialResistance #AnimalHealth #InnovationInAgriculture #NiclosavirLimited

Exciting News from Niclosavir Limited! Born from a pivotal idea during the Covid-19 pandemic, Niclosavir Limited emerged as a beacon of innovation in the fight against antimicrobial resistance (AMR). A novel way to reduce the use of antibiotics in the food chain and the environment. Our journey began with a simple question: Are there alternative pathways to effectively combat viruses, bacterial infections, and even cancer? As we delved deeper into our research, one truth became evident: AMR poses a critical threat to global health. ‘…The rise of antimicrobial resistance will be a central challenge of the 21st Century. In fact, the World Health Organization has said antibiotic resistance is one of the greatest global health challenges we face….’ Consider this 👇🏼 - In 2019, bacterial AMR directly contributed to 1.27 million deaths worldwide and was a factor in 4.95 million more (1). - The misuse and overuse of antimicrobials in humans, animals, and agriculture are the primary culprits driving the rise of drug-resistant pathogens, not to mention the staggering financial costs incurred annually. At Niclosavir Limited, we are committed to pioneering new solutions that not only combat AMR but also pave the way for healthier futures worldwide. If you're interested in learning more about how Niclosavir Ltd could safeguard human and animal health, or if you would like to support our efforts to treat this very costly disease, please get in touch at info@niclosavir.com Visit our website to learn more about our approach: https://lnkd.in/gJV59Cjq Explore the link below to learn more about this urgent global issue: https://lnkd.in/f8AXVGX #AntimicrobialResistance #HealthcareInnovation #GlobalHealth #Biotechnology #NiclosavirLimtied #Mastitis